Barclays’s Progenics Pharmaceuticals Inc PGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-73,821
| Closed | -$280K | – | 4085 |
|
|
2020
Q1 | $280K | Sell |
73,821
-343,593
| -82% | -$1.3M | ﹤0.01% | 2396 |
|
|
2019
Q4 | $2.12M | Buy |
417,414
+220,865
| +112% | +$1.12M | ﹤0.01% | 1835 |
|
|
2019
Q3 | $993K | Sell |
196,549
-32,552
| -14% | -$164K | ﹤0.01% | 2262 |
|
|
2019
Q2 | $1.41M | Buy |
229,101
+99,173
| +76% | +$612K | ﹤0.01% | 2079 |
|
|
2019
Q1 | $603K | Buy |
129,928
+67,436
| +108% | +$313K | ﹤0.01% | 2496 |
|
|
2018
Q4 | $262K | Sell |
62,492
-121,843
| -66% | -$511K | ﹤0.01% | 2608 |
|
|
2018
Q3 | $1.16M | Sell |
184,335
-10,171
| -5% | -$63.8K | ﹤0.01% | 2172 |
|
|
2018
Q2 | $1.56M | Buy |
194,506
+101,242
| +109% | +$814K | ﹤0.01% | 1562 |
|
|
2018
Q1 | $696K | Buy |
93,264
+20,578
| +28% | +$154K | ﹤0.01% | 2058 |
|
|
2017
Q4 | $433K | Sell |
72,686
-13,814
| -16% | -$82.3K | ﹤0.01% | 2199 |
|
|
2017
Q3 | $637K | Buy |
86,500
+18,722
| +28% | +$138K | ﹤0.01% | 1793 |
|
|
2017
Q2 | $459K | Buy |
67,778
+3,118
| +5% | +$21.1K | ﹤0.01% | 1970 |
|
|
2017
Q1 | $610K | Buy |
64,660
+25,305
| +64% | +$239K | ﹤0.01% | 1847 |
|
|
2016
Q4 | $340K | Buy |
39,355
+16,266
| +70% | +$141K | ﹤0.01% | 2028 |
|
|
2016
Q3 | $147K | Buy |
+23,089
| New | +$147K | ﹤0.01% | 2278 |
|
|
2016
Q2 | – | Sell |
-11,892
| Closed | -$48K | – | 3981 |
|
|
2016
Q1 | $48K | Buy |
11,892
+6,523
| +121% | +$26.3K | ﹤0.01% | 2548 |
|
|
2015
Q4 | $31K | Sell |
5,369
-16,117
| -75% | -$93.1K | ﹤0.01% | 2607 |
|
|
2015
Q3 | $107K | Sell |
21,486
-66,783
| -76% | -$333K | ﹤0.01% | 2348 |
|
|
2015
Q2 | $617K | Buy |
88,269
+6,288
| +8% | +$44K | ﹤0.01% | 1688 |
|
|
2015
Q1 | $410K | Buy |
81,981
+61,632
| +303% | +$308K | ﹤0.01% | 2014 |
|
|
2014
Q4 | $143K | Buy |
20,349
+10,237
| +101% | +$71.9K | ﹤0.01% | 2510 |
|
|
2014
Q3 | $51K | Sell |
10,112
-6,953
| -41% | -$35.1K | ﹤0.01% | 2993 |
|
|
2014
Q2 | $68K | Sell |
17,065
-28,849
| -63% | -$115K | ﹤0.01% | 2919 |
|
|
2014
Q1 | $185K | Sell |
45,914
-13,211
| -22% | -$53.2K | ﹤0.01% | 2425 |
|
|
2013
Q4 | $296K | Buy |
59,125
+23,380
| +65% | +$117K | ﹤0.01% | 2413 |
|
|
2013
Q3 | $179K | Sell |
35,745
-24,574
| -41% | -$123K | ﹤0.01% | 2673 |
|
|
2013
Q2 | $269K | Buy |
+60,319
| New | +$269K | ﹤0.01% | 2538 |
|